The global Digestive Enzymes Tablets Market size is expected to reach USD 1,319.8 Million by 2028 at a CAGR of 10.3%, according to a new report by Reports and Data. This can be mainly associated with the rise in awareness of gastrointestinal disorders, muscle improvement and fat reduction supplements. The demand of the market for digestive enzymes is driven by the rising disposable income and changing lifestyles of people around the globe leading to the consequent shift away from healthy diets.
Digestive enzymes are substances that are used to add nutrients to the diet or to lower the risks of health problems, like indigestion, chronic pancreatitis, irritable bowel syndrome, muscle improvement and obesity. The dosage form of digestive enzymes might be in the form of pills, capsules, powders, extracts, or liquids, containing Proteases, Lipases and Amylases.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @https://www.reportsanddata.com/sample-enquiry-form/1251
The pharma and healthcare industry is expected to observe significant growth over the coming years attributed to the increasing incidence of chronic diseases across the globe, growing geriatric patient pool, availability of advanced and minimally invasive surgical and diagnostics procedures, favorable reimbursement scenario, and presence of a robust product pipeline of drugs and therapeutics. In addition, growing integration of IoT, ML, and AI in medical procedures and equipment along with rapid progress in drug design and development. Combination of innovation and technology has brought about massive changes in the healthcare industry and the rapid adoption of telemedicine, remote consultation, and e-prescription have significantly contributed to the revenue growth of the market.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @https://www.reportsanddata.com/report-detail/digestive-enzyme-market
Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register highest market growth over the forecast period attributed to increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.
Request a customization on the report @https://www.reportsanddata.com/request-customization-form/1251
Further key findings from the report suggest
- The market is segmented on the basis of dosage form into tablets, capsules, powder, liquids, and others.
- Tablets segment dominated the market, valued for 21.1% of the digestive enzymes market share in 2020, and is forecasted to have a growth of 8.3% during the forecast period.
- The market is segmented on the basis of product type into carbohydrates, protease, lipase and others.
- Carbohydrates or amylase dominated the market in 2020 with a forecasted CAGR of 10.2%. It is driven by the fact that amylase breaks down the carbohydrates into the sugars that the body needs for energy.
- The market is segmented on the basis of origin into animal, fungi, microbial and plant.
- The animal-origin segment held the largest market share in the market and is forecasted to follow its dominance throughout the forecast period, with a CAGR of 9.5% during the forecast period.
- The efficiency of these animal-originated enzymes in various diseases, such as pancreatitis, exocrine pancreatic insufficiency, and pancreatic cancer, are responsible for driving the growth of the segment
- The market is segmented on the basis of application into Infant Nutrition, Medical Nutrition, Sports Nutrition and Others.
- Medical nutrition segment dominated the market in 2020 and is forecasted to grow with a rate of 9.6% during the forecast period, due to the increasing number of patients suffering from gastrointestinal disorders, rising demand for probiotics and prebiotics among people.
- The market is segmented on the basis of geography by North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
- North America dominated the market in 2020 with a forecasted annual growth of 10.3% during the forecast period.
- The increasing occurrence of chronic gastrointestinal diseases, rising demand for precautionary medicine, and the presence of intense competition among the manufacturers are primary factors contributing to large market size.
- Key participants include Country Life LLC., National Enzyme Company, Rainbow Light Nutritional Systems Inc., Garden Of Life Inc., Biotics Research Corporation, Food State Inc., Matsun Nutrition, Metagenics, Inc., Twinlab Corporation, and Abbott Nutrition, among others.
- The companies have adopted various strategies including mergers, acquisitions and partnerships to hold on going trails and come up with new developments in the market.
For the purpose of this report, Reports and Data have segmented global Digestive Enzymes Tablets Market on the basis of dosage form, product type, origin, application, and region:
Dosage form Outlook (Volume, Kilo tons; 2018-2028 and Revenue, USD Million; 2018-2028)
- Tablets
- Capsules
- Powder
- Liquids
- Others
Product type Outlook (Volume, Kilo tons; 2018-2028 And Revenue, USD Million; 2018-2028)
- Carbohydrates
- Protease
- Lipase
- Others
Origin Outlook (Volume, Kilo tons; 2018-2028 And Revenue, USD Million; 2018-2028)
- Animal
- Fungi
- Microbial
- Plant
Application Outlook (Volume, Kilo tons; 2018-2028 And Revenue, USD Million; 2018-2028)
- Infant Nutrition
- Medical Nutrition
- Sports Nutrition
- Other End uses
Regional Outlook (Volume, Kilo tons; 2018-2028 and Revenue, USD Million; 2018-2028)
- North America
- U.S.
- Europe
- Germany
- UK
- Asia Pacific
- China
- India
- South-east Asia
- Latin America
- Brazil
- MEA
Growing popularity of over-the-counter medications driving market growth
Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.
Restriction on product launches and R&D activities to hamper market growth
Imposition of strict government regulations and shortage of funds have put a halt on the product launches and R&D activities and are expected to restrain market growth over the forecast period. In addition, launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering market growth.
Press Release Available @https://www.reportsanddata.com/press-release/global-digestive-enzyme-market
Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.
Explore More Industry Research by Reports and Data:
Zollinger-Ellison Syndrome Market @ https://www.biospace.com/article/increase-in-availability-of-novel-therapeutic-approaches-is-expected-to-drive-zollinger-ellison-syndrome-market-growth-by-2030-reports-and-data/
Bronchial Spasm Treatment Market @ https://www.biospace.com/article/increasing-number-of-clinical-trials-ongoing-to-avail-newer-and-safer-treatment-options-is-expected-to-drive-bronchial-spasm-treatment-market-growth-by-2030-reports-and-data/
Alport Syndrome Treatment Market @ https://www.biospace.com/article/rising-prevalence-of-genetic-disorders-is-expected-to-drive-alport-syndrome-treatment-market-revenue-growth-by-2030-reports-and-data/
Acute Gout Flare Treatment Market @ https://www.biospace.com/article/increasing-number-of-clinical-trials-ongoing-to-avail-new-and-safe-treatment-options-is-expected-to-drive-acute-gout-flare-treatment-market-growth-by-2030-reports-and-data/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/video
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek